Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitis - Leclercq, Mathilde; Sève, Pascal; Biard, Lucie; Vautier, Mathieu; Maalouf, Georgina; Leroux, Gaëlle; Domont, Fanny; Toutée, Adélaïde; Fardeau, Christine; Sales de Gauzy, Thomas; Touhami, Sara; Kodjikian, Laurent; et al. (British journal of ophthalmology, 2025)
Keywords: Adult; Aged; Antirheumatic Agents; Antirheumatic Agents - therapeutic use; Azathioprine; Azathioprine - therapeutic use; Biopsy; Drug dosages; Drugs; Edema; Female; Follow-Up Studies; Granulomas; Humans; Immunology; Immunosuppressive Agents; Immunosuppressive Agents - therapeutic use; Inflammation; Life Sciences; Macula; Male; Medical imaging; Methotrexate; Methotrexate - therapeutic use; Middle Aged; Mycophenolic Acid; Mycophenolic Acid - therapeutic use; Patients; Retrospective Studies; Santé publique et épidémiologie; Sarcoidosis; Sarcoidosis - complications; Sarcoidosis - drug therapy; Steroids; Treatment Medical; Treatment Outcome; Uveitis; Uveitis - drug therapy; Visual Acuity; Visual Acuity - physiology; Drugs; Macula; Treatment Medical; Inflammation; Immunology